Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Oral Soluble Pellicles for Delayed CINV
NCT06282211Phase 3Recruiting
- Sponsor
- Xinxiang Medical University First Affiliated Hospital
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aiqisu in chemotherapy-induced nausea and vomiting (CINV), sponsored by Xinxiang Medical University First Affiliated Hospital. Started Feb 2024; status: recruiting.
02
Drugs
Aiqisu
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT06282211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282211.